EPD560 Characterization of the microbiome in breast cancer patients diagnosed with COVID-19E-posterEffects of the COVID-19 on key populations
EPB173 Characterization of the absorption, metabolism, and excretion of islatravir, an HIV nucleoside reverse transcriptase translocation inhibitor, in humansE-posterPharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring
EPA094 Characterization of serum and mucosal SARS-CoV-2-antibodies in HIV-1 infected subjects after BNT162b2 mRNA vaccination or SARS-CoV-2 infectionE-posterSARS-Cov2 vaccines
EPA003 Characterization of novel candidate factors impacting HIV life cycleE-posterHIV biology (entry, replicative cycle, transcriptional expression and regulation)
EPA055 Characterization of Hiv-1 intact and near-full length defective proviral populations during long-term suppression on antiretroviral therapyE-posterIdentification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus
EPD065 Characteristics of chemsexers in France during the COVID-19 pandemic: results from the ERAS 2021 national online surveyE-posterGay men other men who have sex with men
OAC0303 Characteristics associated with viral suppression among transgender women with HIV in 7 U.S. cities, NHBS-Trans, 2019-2020Oral abstract session with live Q&ASurveillance of HIV in key populations
EPC169 Characteristics associated with PrEP pilot program participation among MSM in the NetherlandsE-posterDemonstration and pilot projects for prevention (including PrEP, PEP, male circumcision)
EPC404 Characteristics and clinical outcomes of patients receiving HIV diagnoses in emergency departments in Philadelphia, 2014-2019E-posterHIV testing to support identification of new cases of people living with HIV
PESUC23 Characterising the HIV care cascade in Saskatoon, Saskatchewan, 2018 - 2021Poster exhibitionModelling the impact of service models on the HIV epidemic
2101 - 2110 of 2485 items